Sharemaestro Newsreel

NVST|Envista Holdings Corp|Price:26.330|Chg%:+0.140

Envista Holdings Corp (NVST) shows strong fundamentals and high growth potential, despite trading sideways. The company is considered fairly valued within the Healthcare Equipment & Supplies industry and has high institutional ownership. Analysts have a positive outlook, with a 'Buy' rating and a target …

OraSure Technologies, Inc. Revenue Breakdown – LSX:881351

OraSure Technologies, Inc. (LSX:881351) generated 97.93 million EUR in revenue last year, with its Human Immunodeficiency Virus segment contributing the most at 42.40 million EUR. The United States was the largest regional contributor, accounting for 66.63 million EUR of the company's revenue.

EMBC|Embecta Corp|Price:3.295|Chg%:+0.045

Embecta Corp (EMBC) is a global medical device company focusing on diabetes care, offering a portfolio of pen needles, syringes, and safety injection devices. The company's executives and their shareholdings are detailed, with Mr. Devdatt Kurdikar serving as Chairman, President, and CEO. Institutional ownership …

Teleflex Incorporated Revenue Breakdown – NYSE:TFX

Solventum Corp (SOLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Solventum Corp (SOLV), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. According to the analysis, SOLV's price is currently suitable for range-bound swing trading, with a …

AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding

Chad Thomas Campbell, SVP/GM Vascular Access at AngioDynamics (ANGO), received 6,466 shares of common stock from the vesting of performance share units, which were originally granted on July 19, 2023. To cover tax withholding obligations, 2,330 shares were disposed of at $13.82 per share. …

Microbot Medical (MBOT) Short Interest & Short Float | Updated Jul 2026

Microbot Medical (MBOT) currently has 7.49 million shares sold short as of July 15, 2026, representing 11.71% of its public float, which is a 1.92% increase from the prior report. The short interest ratio stands at 10.9 days to cover, indicating a significant level …

Microbot Medical Inc (MBOT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Microbot Medical Inc (MBOT) as of July 24, 2026. The company's valuation score is 8.19, placing it 164th out of 386 in the Biotechnology & Medical Research industry. Key financial metrics like P/E, P/B, and P/CF ratios …

Harvard Bioscience Inc (HBIO) Institutional Confidence

Harvard Bioscience Inc (HBIO) has an institutional shareholding score of 5.00, placing it 108th in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 54.17%, showing a 13.62% increase quarter-over-quarter. James Simons is the largest institutional shareholder, holding 2.25% of outstanding shares.

AngioDynamics (NASDAQ: ANGO) executive settles 20,052 performance units

Warren Nighan Jr., SVP Quality and Regulatory at AngioDynamics (NASDAQ: ANGO), had a 2023 performance share unit grant settle, resulting in 5,694 shares of common stock being issued from a target of 20,052 units. The remaining units were forfeited, and 1,671 shares were withheld …

AngioDynamics Inc. (ANGO) SVP receives 8,047 shares, 4,506 withheld for tax

AngioDynamics Inc.'s SVP International, Laura Piccinini, received 8,047 common shares from the vesting of performance share units granted in July 2023. Of these, 4,506 shares were withheld for tax obligations at $13.82 per share, and the remaining 20,289 units from the original grant were …

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors

West Pharmaceutical Services Inc. (WST) stock fell 7.67% on Friday, closing at $328.20. This underperformance occurred despite a positive trading session for the broader market, with the S&P 500 rising 0.05% and the Dow Jones Industrial Average rising 0.46%. This marks the stock's third …

Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?

Baxter International Inc. (BAX) is scheduled to release its second-quarter 2026 results on July 30, with expectations of continued operational headwinds impacting performance. The company anticipates revenue decline and a significant drop in earnings per share due to manufacturing inefficiencies, inflationary pressures, and issues …

Azenta, Inc. Revenue Breakdown – LSE:0HQ1

Azenta, Inc. (LSE:0HQ1) generated a total revenue of $593.82 million USD last year. The Sample Management Solutions segment was the top-performing segment, contributing $324.59 million USD, while the United States was the largest regional contributor with $365.00 million USD in revenue.

BioLife Solutions (BLFS) Faces Fairness Probes After Repligen Agrees To Buy It

BioLife Solutions (BLFS) is facing fairness probes from several law firms after Repligen agreed to acquire the company. The investigations focus on ensuring the transaction terms are fair to BioLife Solutions shareholders, considering the agreed US$31.00 per share price which includes a mix of …

Pulse Biosciences, Inc Revenue Breakdown – NASDAQ:PLSE

This article provides a detailed revenue breakdown for Pulse Biosciences Inc (PLSE), categorizing its revenue by business segments (Systems, Cycle units) and geographical regions (North America, Rest of World). The data presented shows that as of the updated information on Tuesday, January 6, the …

Anteris Technologies Global Corp (AVR) Financials

This article provides a detailed financial overview of Anteris Technologies Global Corp (AVR), including its income statement, balance sheet, and cash flow statement. It highlights key financial indicators such as EPS, revenue, net profit, and various ratios, alongside upcoming earnings dates and analyst ratings. …

Earnings Flash (ATRC) AtriCure, Inc. Posts Q2 Adjusted EPS $0.18 per Share, vs. FactSet Est of $0.00

AtriCure, Inc. (ATRC) reported strong Q2 adjusted earnings per share of $0.18, significantly surpassing the FactSet estimate of $0.00. The company also announced Q2 revenue of $153.6 million, exceeding the FactSet estimate of $151.8 million, and provided an optimistic full-year 2026 adjusted EPS guidance …

Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Hold Rating

Morgan Stanley has reiterated its Hold rating on Dentsply Sirona (XRAY.US). The firm also maintained its price target for the company.

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of BioLife Solutions, Inc. (NasdaqCM: BLFS) to Repligen Corporation (NasdaqGS: RGEN). KSF is concerned that the offered consideration of $11.25 in cash and 0.1442 shares of Repligen common stock per BioLife share may …

UTMD|Utah Medical Products Inc|Price:67.140|Chg%:+2.960

Utah Medical Products Inc (UTMD) shows strong fundamentals and high growth potential, despite a weak stock market performance recently. Its valuation is considered fairly valued within the Healthcare Equipment & Supplies industry. The company is in a growing phase with high and stable dividends, …

SOLN5957403 Bond Profile — Key Metrics

This article provides key metrics for the Solventum Corporation 5.45% 13-MAR-2031 bond, identified as SOLN5957403 FINRA. It details the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. Solventum Corp. is described as a healthcare company founded on January …

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics experienced stock declines following concerns about a rising number of uninsured patients, as highlighted in HCA Healthcare's recent earnings report. HCA reported a "negative payer mix shift" leading to a $400 million reduction …

Sanara Medtech Inc (SMTI) Institutional Confidence

Sanara Medtech Inc (SMTI) currently holds an institutional shareholding score of 3.00, placing it 92nd out of 155 companies in the Pharmaceuticals industry. The institutional shareholding proportion has increased by 18.63% quarter-over-quarter to 15.50%. James Simons is the largest institutional shareholder, holding 0.71% of …

Robotics firm Brooks Automation weighs IPO - Bloomberg By Investing.com

Brooks Automation, a robotics and software automation company, is reportedly considering an initial public offering. The company, backed by Thomas H. Lee Partners, was formed after a $3 billion carve-out from the former Brooks Automation, with its life sciences arm renamed Azenta Inc. Deliberations …

Align Unveils New Digital Dentistry Innovations

Align Technology has introduced new innovations within its Align Digital Platform, designed to enhance the visualization, planning, and treatment aspects of digital dentistry. These updates include improved patient communication tools, more precise treatment planning capabilities for Invisalign cases, and streamlined workflows for both orthodontic …

Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Intuitive Surgical revealed a five layer AI framework for its surgical platforms. The company …

AtriCure, Inc. Revenue Breakdown – NASDAQ:ATRC

LMAT|LeMaitre Vascular Inc|Price:98.390|Chg%:+0.900

LeMaitre Vascular Inc. (LMAT) is a company that develops, manufactures, and markets devices and services for the treatment of peripheral vascular disease. The article provides an overview of the company, including its stock performance, market capitalization, P/E ratio, and executive team. It also lists …

POCI|Precision Optics Corporation Inc|Price:4.300|

Precision Optics Corporation Inc (POCI) shows relatively healthy fundamentals and high growth potential, with its valuation considered fairly valued. Institutional ownership is high, and analysts have issued a "Buy" rating with a target price of $8.00. The stock is currently trading sideways, suggesting potential …

Precision Optics Corporation Inc (POCI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Precision Optics Corporation Inc (POCI), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that POCI's stock is currently trading between a resistance level of 5.10 and a support level of …

Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal S

Alcon Inc (ALC) has partnered with the Aravind Eye Care System to launch the Aravind Alcon Global Centre of Excellence for Vitreoretinal Surgery Training in Coimbatore, aiming to enhance specialized surgical education in ophthalmology. This initiative follows their previous collaboration on a Global Cataract …

Nyxoah SA (NYXH) Valuation: PE, PB & Fair Value Analysis

Nyxoah SA (NYXH) has a current valuation score of 8.53, placing it 85 out of 200 in the Healthcare Equipment & Supplies industry. Its P/E ratio is -0.76, significantly below its recent high and above its recent low. Key valuation metrics like P/E, P/B, …

NEPH|Nephros Inc|Price:3.450|Chg%:-0.190

This article provides a comprehensive stock analysis of Nephros Inc (NEPH) based on TradingKey's stock score system. It highlights the company's healthy fundamentals, high growth potential with steady revenue growth, and relatively fair valuation. The analysis also covers institutional ownership, analyst ratings, and a …

WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook

WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 13.8% year on year to $872.3 million. Guidance for next quarter's revenue was …

Envista Holdings Corp (NVST) Financial Health: Profitability & Balance Sheet Analysis

Envista Holdings Corp (NVST) has a robust financial score of 8.14, ranking 40th in the Healthcare Equipment & Supplies industry. The company has shown strong financial performance with a 14.36% year-over-year revenue increase to $705.50 million and a significant 115.00% year-over-year net profit increase …